Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Tag:
news
AADE Rebrands, Changes Name to ADCES
On January 22, 2020, the organization formerly known as the American Association of Diabetes Educators (AADE) announced a change to the organization's name to the Association of Diabetes Care and...
Beyond Type 2 Celebrates Two Years, Launches New Community Platform
Today, global diabetes nonprofit Beyond Type 1 celebrates the two year anniversary of the launch of Beyond Type 2 - a digital platform for those impacted by Type 2 diabetes, available in English and S...
Beyond Type 2 Celebrates One Year Anniversary, Adds New Partner
Today, global diabetes non-profit Beyond Type 1 celebrates the one year anniversary of the launch of Beyond Type 2 - a platform and community serving those impacted by Type 2 diabetes. In 2020, Beyond...
Researchers See Type 2 Diabetes Develop for the First Time
Researchers have seen Type 2 diabetes (T2D) develop for the first time. A study published this month in Cell Metabolism shows excess fat that spills over from the liver into the pancreas may cause T2D...
FDA Investigating Contaminated Metformin, Risk is Low for Type 2 Patients
The FDA, Health Canada, and European Union investigate the presence of cancer-causing NDMA in Type 2 diabetes drug, metformin. The risk to patients is very low.
Farxiga Approved in the United States to Treat Heart Failure
On Monday, October 21, 2019, the U.S. Food and Drug Administration (FDA) approved AstraZeneca's diabetes drug, Farxiga, for use in the U.S. to treat and reduce the risks of hospitalization from h...
Abbott and Omada Health Partner to Help People With Type 2 Diabetes
On October 14, 2019, Abbott and Omada Health announced a partnership to integrate Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) with Omada Health's digital program for ...
FDA Approves Invokana to Treat Diabetic Kidney Disease
On Monday, September 30, 2019, the U.S. Food and Drug Administration (FDA) approved a new indication for the Janssen Pharmaceutical Companies of Johnson & Johnson's INVOKANA (canagliflozin) t...
FDA Approves First Oral Semaglutide Rybelsus from Novo Nordisk
On September 20, the FDA approved the first oral GLP-1 Rybelsus (semaglutide). Manufactured by Novo Nordisk, the GLP-1 drug showed impressive efficacy in the PIONEER Trial results presented at EASD 20...
Study Shows Combination Therapy Leads to Better Outcomes for Newly Diagnosed T2D Patients
The new study shows combination therapy in patients newly diagnosed with type 2 diabetes provides better outcomes than metformin alone.
Posts navigation
←
Newer
Posts
1
…
7
8
9
Older
Posts
→